Clinical Trial

Predictors of Poor Prognosis in HFpEF

Name: Predictors of Poor Prognosis in HFpEF — clinical trial record (NCT06844032)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Patients with HFpEF who have undergone meticulous clinical and instrumental evaluation (including diastolic exercise testing) between 2013 and 2020, will be followed up for at least 3 years.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-02-19; most recent amendment 2026-04-14.

Trial Details

NCT Number	NCT06844032
Lead Sponsor	National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Conditions	HFpEF
Enrollment	500 participants
Start Date	2022-01-31
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-17